Mereo Biopharma Group Plc(MREO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

MREO Mereo Biopharma Group Plc

Trading 02-03 11:48:28 EST

0.4523

+0.0198

+4.58%

High0.4650	Low0.4369	Vol1.36M
Open0.4506	D1 Closing0.4325	Amplitude6.50%
Mkt Cap71.98M	Tradable Cap45.44M	Total Shares159.13M
T/O608.19K	T/O Rate1.35%	Tradable Shares100.47M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"MREO","market":"US","secType":"STK","nameCN":"Mereo Biopharma Group Plc","latestPrice":0.4523,"timestamp":1770137298991,"preClose":0.4325,"halted":0,"volume":1356779,"delay":0,"changeRate":0.04578034682080921,"floatShares":100470459,"shares":159131700,"eps":-0.261249,"marketStatus":"Trading","change":0.0198,"latestTime":"02-03 11:48:28 EST","open":0.4506,"high":0.465,"low":0.4369,"amount":608190.89423436,"amplitude":0.064971,"askPrice":0.4551,"askSize":20,"bidPrice":0.4522,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.261249,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1770152400000},"marketStatusCode":2,"adr":0,"adrRate":5,"listingDate":1556078400000,"exchange":"NASDAQ","adjPreClose":0.4325,"preHourTrading":{"tag":"盘前","latestPrice":0.455,"preClose":0.4325,"latestTime":"09:27 EST","volume":29703,"amount":13249.1508729,"timestamp":1770128872623,"change":0.0225,"changeRate":0.052023,"amplitude":0.054335},"postHourTrading":{"tag":"盘后","latestPrice":0.4317,"preClose":0.4325,"latestTime":"19:59 EST","volume":17500,"amount":7606.8709,"timestamp":1770080363543,"change":-0.0008,"changeRate":-0.00185,"amplitude":0.049711},"volumeRatio":0.623963,"impliedVol":2.3473,"impliedVolPercentile":0.8406},"requestUrl":"/m/hq/s/MREO","defaultTab":"news","newsList":[{"id":"2608803179","title":"European Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2608803179","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608803179?lang=en_us&edition=fundamental","pubTime":"2026-02-04 00:10","pubTimestamp":1770135009,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were trending lower late Tuesday morning, declining 0.17% to 1,828.18 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biotech firm Evaxion  and biopharmaceutical company DBV Technologies , which climbed 7.1% and 5.2% respectively. They were followed by biopharmaceutical company argenx  and lender ING , which advanced 2% and 1.6% respectively.The decliners from continental Europe were led by internet browser company Opera  and software firm SAP , which dropped 7.3% and 4.2% respectively. They were followed by biopharmaceutical company Cellectis  and 3D printer company Materialise , which lost 2.3% and 1.8% respectively.From the UK and Ireland, the gainers were led by mining company BHP Group  and biopharmaceutical company Mereo BioPharma Group , which rose 4.8% and 4.1% respectively. They were followed by biotech firm Autolus Therapeutics  and telecommunications operator Vodafone Group","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AFG","CLLS","BK4107","IE00BJJMRZ35.SGD","VOD","ING","BK7095","ARGX","LU0320765992.SGD","LU2324357040.USD","MREO","BK4168","WPP.AU","BK7507","IE00B4R5TH58.HKD","BK7511","DBVT","BK4613","BK7505","BK4132","BK4528","DAVA","IE0002141913.USD","LU1983260115.SGD","BCYC","LU0648005311.SGD","LU0889565916.HKD","LU0109394709.USD","AUTL","BHP.AU","IE0009355771.USD","OPRA","BK4204","DAVA.AU","ING.AU","PSO","IE00BFTCPJ56.SGD","LU0084288595.USD","IE0034235188.USD","BHP","BK4009","EVAX","BK4134","WPP","IE00B2B36J28.USD","MTLS","SAP","BK4585","IE00BJT1NW94.SGD","BK4546"],"gpt_icon":0},{"id":"2608893003","title":"European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2608893003","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608893003?lang=en_us&edition=fundamental","pubTime":"2026-02-03 00:09","pubTimestamp":1770048544,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts opened the week higher, rising 0.8% late Monday morning to 1,824.45 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by internet browser company Opera  and furniture maker Natuzzi , which climbed 16.1% and 8.1% respectively. They were followed by biopharmaceutical company DBV Technologies  and software firm SAP , which advanced 3% and 2.3% respectively.The decliners from continental Europe were led by semiconductor company Sequans Communications  and biotech firm BioNTech , which dropped 7.2% and 3.8% respectively. They were followed by petroleum refiner Equinor  and pharmaceutical company Novo Nordisk , which lost 3.4% and 1.1% respectively.From the UK and Ireland, the gainers were led by cruise line operator Carnival , which rose 5.4%, followed by hospitality company InterContinental Hotels Group  and software firm Endava , which gained 2.5% each, and biotech company Trinity Biotech , w","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EQNR","BK4141","BK4142","BK4532","IE00BKVL7J92.USD","BK4528","BK4095","NTZ","DGE.UK","DAVA","BK4548","DEO","LU0648005311.SGD","WPP","BK4585","BK4535","TRIB","BDRX","BK4117","BK4599","LU1093756325.SGD","BK4568","BK4201","BK4023","BK4588","BK4613","BK4134","LU0154236417.USD","BK4007","DBVT","SAP","CUK","BK4139","BK4559","IHG","BK4169","BK4505","BK7104","LU1093756168.USD","MREO","BK4082","BK4009","IE00BZ1G4Q59.USD","BNTX","SQNS","BK4551","OPRA","BK4107","LU0084288595.USD"],"gpt_icon":1},{"id":"2607187037","title":"Update: European Equities Traded in the US as American Depositary Receipts Track Lower in Thursday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2607187037","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607187037?lang=en_us&edition=fundamental","pubTime":"2026-01-30 01:26","pubTimestamp":1769707581,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were down late Thursday morning, declining 0.82% to 1,802.03 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by petroleum refiner Equinor , which rose 1.9%. They were followed by brewing company Anheuser-Busch InBev  and oil and gas company Eni , which were up 1.5% and 1.2% respectively.The decliners from continental Europe were led by software firm SAP  and telecommunications company Nokia , which dropped 17% and 9.3% respectively. They were followed by semiconductor company Sequans Communications  and internet browser company Opera , which lost 8.3% and 4.4% respectively.From the UK and Ireland, the gainers were led by cruise line operator Carnival  and mining company BHP Group , which advanced 7% and 2.1% respectively. They were followed by oil and gas company Shell  and pharmaceutical company GSK , which increased 1.9% and 1.8% respectively.The decliners from the UK and Ireland were ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4107","BK4007","IE00BMPRXN33.USD","TRIB","EQNR","BK4020","LU0300736062.USD","LU1829250122.USD","SQNS","BK4588","NOK","BK4117","BK4139","LU0300736492.USD","BK7119","MREO","BHP","BHP.AU","LU0278409577.USD","BK4528","BUD","BK4613","AFG","NCNA","CUK","BK4082","GSK.UK","BK7507","E","SHEL","LU0098860793.USD","IE00BMPRXR70.SGD","GSK","OPRA","BK4168","BK4505","BK4142","LU0320765646.SGD","LU1162221912.USD","BK4023","BK7095","LU2236285917.USD","BK4158","BK4532","BUD.AU","BK4585","BDRX","BK4547","SAP"],"gpt_icon":0},{"id":"2607323745","title":"European Equities Traded in the US as American Depositary Receipts Fall Sharply in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2607323745","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607323745?lang=en_us&edition=fundamental","pubTime":"2026-01-29 00:16","pubTimestamp":1769616962,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts fell sharply late Wednesday morning, dropping 1.35% to 1,820.75 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by internet browser company Opera  and accommodations booking site trivago , which rose 4.1% and 0.7% respectively. They were followed by software firm SAP  and internet advertising firm Criteo , which were up 0.6% and 0.3% respectively.The decliners from continental Europe were led by biopharmaceutical company Cellectis  and pharmaceutical company Ascendis Pharma , which fell 4% and 3.8% respectively. They were followed by biotech firm Evaxion  and lender Banco Bilbao Vizcaya Argentaria , which were down 3.7% and 3.4% respectively.From the UK and Ireland, the gainers were led by insurance firm Prudential  and alcoholic beverage company Diageo , which advanced 1.4% and 0.9%, respectively. They were followed by educational publisher Pearson , which increased 0.7%.The decliners f","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SAP","LU0109394709.USD","TRIB","BK4077","BK4107","PSO","IE00BFMHRM44.USD","PUK","ASND","BK4613","OPRA","BCYC","BK4559","CRTO","LU0889565916.HKD","BK4585","MREO","CLLS","DEO","BK4204","BDRX","BK4139","TRVG","LU0320765992.SGD","DGE.UK","BK4023","BK4207","BK4528","BK4169","BK4082","BBVA","BK4111","AFG","BK4117","BK4588","BK4009","EVAX","BK4505","BK4162"],"gpt_icon":0},{"id":"2606244194","title":"European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2606244194","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606244194?lang=en_us&edition=fundamental","pubTime":"2026-01-27 00:06","pubTimestamp":1769443590,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts started the week sharply higher late Monday morning, rising 1.21% to 1,812.72 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by pharmaceutical company Novo Nordisk  and software firm SAP , which rose 2.4% and 2.1%, respectively. They were followed by lender Banco Santander  and telecommunications company Ericsson , which were up 2% and 1.8%, respectively.The decliners from continental Europe were led by biopharmaceutical companies Cellectis  and DBV Technologies , which fell 6.4% and 3.1%, respectively. They were followed by semiconductor company Sequans Communications  and pharmaceutical company Ascendis Pharma , which were down 2.8% and 0.9%, respectively.From the UK and Ireland, the gainers were led by mining company BHP Group  and utilities company National Grid , which advanced 2.1% and 1.8%, respectively. They were followed by pharmaceutical company GSK  and lender Lloyds Banking ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1829250122.USD","TRIB","BK7511","LU1093756325.SGD","BK7142","SQNS","BK7507","BHP","LU1093756168.USD","LU0889565916.HKD","DBVT","AUTL","GSK.UK","BK4515","LYG","IE00BKVL7J92.USD","BK4554","BK4168","BK4528","BK4208","BK4521","BK4007","LU0300736062.USD","BK4588","CLLS","BK4532","LU0154236417.USD","BK4207","BK4505","BK4023","BK4107","LU0109394709.USD","MREO","BK4585","LU0300736492.USD","IE00BZ1G4Q59.USD","SAN","BK4613","ASND","NVO","BK4141","BK4082","BK7104","ERIC","LU0320765992.SGD","BK4591","BK7095","NGG","BK4020","BK4117","BK4139","SAP","BK4599","AMRN","GSK"],"gpt_icon":1},{"id":"2605429578","title":"Dalaroo launches exploration blitz on epic Greenland rare earths play","url":"https://stock-news.laohu8.com/highlight/detail?id=2605429578","media":"The West Australian","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605429578?lang=en_us&edition=fundamental","pubTime":"2026-01-23 06:05","pubTimestamp":1769119552,"startTime":"0","endTime":"0","summary":"Dalaroo Metals is charging ahead with a high-octane 2026 exploration blitz at its flagship Blue Lagoon critical minerals project in Greenland, hot on the heels of a knockout reconnaissance program in 2025.","market":"nz","thumbnail":"https://images.thewest.com.au/publication/C-21399938/99bc18ffc327961802e48b1b751407723c0ed76f.jpg","type":0,"news_type":0,"thumbnails":["https://images.thewest.com.au/publication/C-21399938/99bc18ffc327961802e48b1b751407723c0ed76f.jpg"],"rights":{"source":"thewest_stock","url":"https://thewest.com.au/business/bulls-n-bears/dalaroo-launches-exploration-blitz-on-epic-greenland-rare-earths-play-c-21399938","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://thewest.com.au/business/bulls-n-bears/dalaroo-launches-exploration-blitz-on-epic-greenland-rare-earths-play-c-21399938","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"thewest_stock","symbols":["BK4505","BK4139","MREO"],"gpt_icon":0},{"id":"2605592117","title":"European Equities Traded in the US as American Depositary Receipts Fall in Tuesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2605592117","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605592117?lang=en_us&edition=fundamental","pubTime":"2026-01-21 00:04","pubTimestamp":1768925057,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were tracking lower late Tuesday morning, declining 1.17% to 1,742.51 on the S&P Europe Select ADR Index.From continental Europe, the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4201","TTE","LU1829250122.USD","LU2237443382.USD","TRIB","SQNS","BK4111","LU2237443622.USD","DBVT","LU2237443978.SGD","LU2462157665.USD","LYG","LU2456880835.USD","LU2129689431.USD","BK4568","BK4077","BK4007","OPRA","BK4588","BK4532","BK4505","BK4023","BK4107","BCYC","BK4204","EDAP","EVAX","LU0109394709.USD","LU2236285917.USD","LU2237443549.SGD","LU2237443895.HKD","MREO","LU2129689605.HKD","PSO","BK4585","TRVG","VOD","ASND","BK4141","BK4082","LU0320765992.SGD","AFG","AZN","NCNA","BK4117","BK4139","LU2237443465.HKD","BK4561","LU0889565916.HKD","LU2129689514.USD"],"gpt_icon":0},{"id":"2604156686","title":"Australian Rare Earths Defines High-Purity MREO Pathway at Koppamurra","url":"https://stock-news.laohu8.com/highlight/detail?id=2604156686","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604156686?lang=en_us&edition=fundamental","pubTime":"2026-01-20 06:39","pubTimestamp":1768862374,"startTime":"0","endTime":"0","summary":"Australian Rare Earths Limited ( ($AU:AR3) ) has issued an update. Australian Rare Earths has reported a key metallurgical breakthrough at its Kopp...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/australian-rare-earths-defines-high-purity-mreo-pathway-at-koppamurra?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/australian-rare-earths-defines-high-purity-mreo-pathway-at-koppamurra?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MREO","BK4505"],"gpt_icon":0},{"id":"2604322371","title":"Analysts’ Top Healthcare Picks: Telix Pharmaceuticals (TLPPF), Mereo Biopharma Group Plc (MREO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2604322371","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604322371?lang=en_us&edition=fundamental","pubTime":"2026-01-20 00:40","pubTimestamp":1768840832,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Telix Pharmaceuticals (TLPPF – Research Report), Mer...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-telix-pharmaceuticals-tlppf-mereo-biopharma-group-plc-mreo-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-telix-pharmaceuticals-tlppf-mereo-biopharma-group-plc-mreo-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MREO","TLX","TLPPF","LU0128526141.USD","LU0029874061.USD","BK4581","HCSG","LABU","XBI","BK4585","BK4588","BK4137","XLV","BK4505","BK4139"],"gpt_icon":0},{"id":"2604107809","title":"A Look At Mereo BioPharma Group (MREO) Valuation After Mixed Setrusumab Phase 3 Results And Cash Runway Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2604107809","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604107809?lang=en_us&edition=fundamental","pubTime":"2026-01-17 08:28","pubTimestamp":1768609725,"startTime":"0","endTime":"0","summary":"Mereo BioPharma Group (NasdaqCM:MREO) has come into focus after releasing mixed Phase 3 results for setrusumab in osteogenesis imperfecta, along with a cash runway update to mid-2027 and progress on its alvelestat and vantictumab programs.\nSee our latest analysis for Mereo BioPharma Group.\nThe mixed Phase 3 readout and cash runway update come after a volatile stretch for the stock, with a 7 day share price return of 29.45% following a 30 day share price return decline of 66.67%, and a 1 year...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mreo/mereo-biopharma-group/news/a-look-at-mereo-biopharma-group-mreo-valuation-after-mixed-s","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mreo/mereo-biopharma-group/news/a-look-at-mereo-biopharma-group-mreo-valuation-after-mixed-s","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MREO","BK4505","BK4139"],"gpt_icon":0},{"id":"2604891829","title":"Mereo BioPharma Group Price Target Maintained With a $1.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2604891829","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604891829?lang=en_us&edition=fundamental","pubTime":"2026-01-17 01:32","pubTimestamp":1768584720,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MREO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 16, 2026 12:32 ET (17:32 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MREO","BK4505","BK4139"],"gpt_icon":0},{"id":"2604990331","title":"European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading; Rise 2% for Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2604990331","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604990331?lang=en_us&edition=fundamental","pubTime":"2026-01-17 00:14","pubTimestamp":1768580089,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were down late Friday morning, falling 0.79% to 2,881.99 on the S&P Europe Select ADR Index, which was up 2% for the week.From contin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BNTX","LU1829250122.USD","PSO","BP","BK4548","EDAP","LU0072461881.USD","BK4568","LU0320765646.SGD","MREO","IE00BKVL7J92.USD","NGG","BK4009","BK4007","BK7095","BK4588","CRTO","LU0320765992.SGD","LU0162691827.USD","BK4599","IE00BFMHRM44.USD","BCYC","BK4208","DBVT","BK4111","BK4585","BK4201","SLN","BK4107","LU1093756168.USD","ASND","IE00BZ1G4Q59.USD","NVO","BK7507","BK7104","LU0300736062.USD","BK4168","LU0300736492.USD","LU0154236417.USD","LU0109394709.USD","BDRX","BHP","PHG","BK4535","BK7511","BK4117","BK4204","BK4532","BK4139","BK4551","EQNR","LU0889565916.HKD","BK4505","LU1093756325.SGD","BK4082","LU1162221912.USD"],"gpt_icon":1},{"id":"2603993023","title":"Dalaroo soars as Greenland punt pays off with critical minerals surge","url":"https://stock-news.laohu8.com/highlight/detail?id=2603993023","media":"The West Australian","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603993023?lang=en_us&edition=fundamental","pubTime":"2026-01-16 01:30","pubTimestamp":1768498211,"startTime":"0","endTime":"0","summary":"Dalaroo Metals has unearthed a broad, high-grade rare earths and zirconium-hafnium system at its Blue Lagoon project in Greenland, extending over a 2.7km strike, pointing to a new district-scale discovery.","market":"hk","thumbnail":"https://images.thewest.com.au/publication/C-21324967/fd0b708d5881fea6e3c7730589ed643e25baefee.jpg","type":0,"news_type":0,"thumbnails":["https://images.thewest.com.au/publication/C-21324967/fd0b708d5881fea6e3c7730589ed643e25baefee.jpg"],"rights":{"source":"thewest_stock","url":"https://thewest.com.au/business/bulls-n-bears/dalaroo-soars-as-greenland-punt-pays-off-with-critical-minerals-surge-c-21324967","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://thewest.com.au/business/bulls-n-bears/dalaroo-soars-as-greenland-punt-pays-off-with-critical-minerals-surge-c-21324967","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"thewest_stock","symbols":["BK4505","BK4139","MREO"],"gpt_icon":0},{"id":"2603810769","title":"European Equities Traded in the US as American Depositary Receipts Little Changed in Thursday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2603810769","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603810769?lang=en_us&edition=fundamental","pubTime":"2026-01-16 00:12","pubTimestamp":1768493579,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were little changed late Thursday morning, edging 0.02% higher to 1,753.96 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by telecommunications company Nokia  and internet browser company Opera , which rose 4.6% and 3.2%, respectively. They were followed by biopharmaceutical company DBV Technologies  and telecommunications company Ericsson , which were up 1.7% and 1%, respectively.The decliners from continental Europe were led by pharmaceutical company Novo Nordisk  and medical device maker EDAP TMS , which fell 3.8% and 3.7%, respectively. They were followed by oil and gas company Eni  and biopharmaceutical company Grifols , which were down 2.5% and 1.7%, respectively.From the UK and Ireland, the gainers were led by biopharmaceutical company Biodexa Pharmaceuticals  and lender HSBC , which advanced 5.2% and 1.2%, respectively. They were followed by telecommunications operator Vodafone ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0154236417.USD","BK4505","GRFS","BK4020","BK4515","BK4107","NOK","ERIC","AFG","BK4599","EDAP","GSK","DGE.UK","LU0889565916.HKD","LU1829250122.USD","BK4588","LU1093756168.USD","LU2236285917.USD","IE00BZ1G4Q59.USD","HSBC","LU1267930227.SGD","LU0128525689.USD","BK4139","BK4132","DEO","LU0310800965.SGD","BDRX","BK4521","NVO","MREO","VOD","BK4547","BK4568","BK4559","DBVT","BK4201","BK4591","BK4169","OPRA","GSK.UK","NVO.AU","LU2456880835.USD","E","AZN","LU0109394709.USD","AKTX","IE00BKVL7J92.USD","LU0052756011.USD","BK4207","BK4023"],"gpt_icon":1},{"id":"2603648316","title":"European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2603648316","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603648316?lang=en_us&edition=fundamental","pubTime":"2026-01-15 00:08","pubTimestamp":1768406922,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts are tracking higher late Wednesday morning, rising 0.44% to 1,753.15 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical company Grifols  and semiconductor company Sequans Communications , which advanced 5.2% and 5.1%, respectively. They were followed by telecommunications operator Telefonica  and petroleum refiner Equinor , which increased 2.8% and 1.5%, respectively.The decliners from continental Europe were led by biopharmaceutical company Cellectis  and 3D printer company Materialise , which lost 4.9% and 1.3%, respectively. They were followed by internet browser company Opera  and software firm SAP , which were down 1.1% and 1%, respectively.From the UK and Ireland, the gainers were led by biopharmaceutical company Mereo BioPharma Group  and software firm Endava , which rose 9.3% and 4.8%, respectively. They were followed by pharmaceutical company Silence Therapeuti","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SLN","MTLS","OPRA","BK4023","DAVA","BDRX","BK7511","BK4585","BK4505","BK4201","NCNA","LU0084288595.USD","GRFS","BK4115","BK4134","EQNR","BK4111","BK4141","PSO","LU0300736492.USD","TELFY","BK4107","TEF","CLLS","BK4117","BK4204","BK4528","BK4613","LU0300736062.USD","BK7095","BK4546","BK4082","BK4588","SAP","SQNS","BK4139","TRIB","DAVA.AU","AFG","BK7507","BHP","BHP.AU","LU0648005311.SGD","BK4168","MREO"],"gpt_icon":0},{"id":"2603155638","title":"Cantor Fitzgerald Sticks to Their Buy Rating for Mereo Biopharma Group Plc (MREO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2603155638","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603155638?lang=en_us&edition=fundamental","pubTime":"2026-01-13 22:37","pubTimestamp":1768315061,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Kristen Kluska from Cantor Fitzgerald maintained a Buy rating on Mereo Biopharma Group Plc, with a price target of ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cantor-fitzgerald-sticks-to-their-buy-rating-for-mereo-biopharma-group-plc-mreo-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cantor-fitzgerald-sticks-to-their-buy-rating-for-mereo-biopharma-group-plc-mreo-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MREO"],"gpt_icon":0},{"id":"2603451686","title":"Mereo BioPharma Group Is Maintained at Buy by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2603451686","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603451686?lang=en_us&edition=fundamental","pubTime":"2026-01-13 20:04","pubTimestamp":1768305840,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MREO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 13, 2026 07:04 ET (12:04 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","MREO"],"gpt_icon":0},{"id":"2603683429","title":"Mereo Biopharma Group Plc : Needham Cuts Target Price to $3 From $5","url":"https://stock-news.laohu8.com/highlight/detail?id=2603683429","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603683429?lang=en_us&edition=fundamental","pubTime":"2026-01-13 19:27","pubTimestamp":1768303622,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nFWN3YE0IU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","BK4139","MREO"],"gpt_icon":0},{"id":"2602517046","title":"Mereo BioPharma Extends Cash Runway to Mid-2027 and Updates Setrusumab and Alvelestat Program Status","url":"https://stock-news.laohu8.com/highlight/detail?id=2602517046","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602517046?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:00","pubTimestamp":1768222825,"startTime":"0","endTime":"0","summary":"Mereo BioPharma Group plc provided a corporate update, highlighting ongoing analyses of data from the Orbit and Cosmic Phase 3 studies of setrusumab  for osteogenesis imperfecta  to determine the potential path forward for the program. The company reported a cash balance of approximately $41 million as of December 31, 2025, and updated its runway guidance to mid-2027 following reductions and delays in pre-commercial and manufacturing activities related to setrusumab. Mereo continues to assess the totality of the Phase 3 trial data and is considering potential interactions with regulators. For its alvelestat  program in alpha-1 antitrypsin deficiency-associated lung disease , Mereo is preparing for a global Phase 3 pivotal study. The anticipated trial will enroll approximately 220 patients and evaluate alvelestat over an 18-month period. The primary efficacy endpoint for U.S. approval is the St. George's Respiratory Questionnaire  Total Score, while lung density measured by CT scan will","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL5FcrxK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","IE00BGHQF748.EUR","BK4588","MREO","LU2210149790.SGD","LU2095319765.USD","SG9999014013.SGD","BK4585","BK4139","BK4112","IE00B3QW5Z07.USD","LU2210150020.SGD","IE00BKPKM429.USD","LU0314104364.USD","BK4505","SG9999014021.USD","IE00B64PRP62.GBP","SG9999014005.SGD","NDAQ"],"gpt_icon":0},{"id":"2601369321","title":"Mereo BioPharma CEO to Present at J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2601369321","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601369321?lang=en_us&edition=fundamental","pubTime":"2026-01-08 20:14","pubTimestamp":1767874441,"startTime":"0","endTime":"0","summary":"Mereo BioPharma Group plc will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026, at 1:30pm PT / 9:30pm GMT. Chief Executive Officer Dr. Denise Scots-Knight will deliver the presentation, and a live audio webcast will be available for those interested in attending virtually.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mereo BioPharma Group plc published the original content used to generate this news brief on January 08, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nNDL5KkQ0M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4505","MREO"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.mereobiopharma.com","stockEarnings":[{"period":"1week","weight":-0.1211},{"period":"1month","weight":-0.1526},{"period":"3month","weight":-0.757},{"period":"6month","weight":-0.728},{"period":"1year","weight":-0.8563},{"period":"ytd","weight":0.0379}],"compareEarnings":[{"period":"1week","weight":0.0039},{"period":"1month","weight":0.0179},{"period":"3month","weight":0.0299},{"period":"6month","weight":0.099},{"period":"1year","weight":0.1555},{"period":"ytd","weight":0.0198}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally. It develops Etigilimab (MPH-313), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the treatment of tumors. The company is also developing Navicixizumab (OMP-305B83), which has completed Phase 1b clinical trials for the treatment of the late line ovarian cancer; Acumapimod (BCT-197), a p38 MAP kinase inhibitor that is in Phase II clinical trials to treat acute exacerbations of chronic obstructive pulmonary disease; and Leflutrozole (BGS-649), an oral aromatase inhibitor for the treatment of hypogonadotropic hypogonadism which is in Phase 2 trials. In addition, it develops rare disease product candidates, including Setrusumab (BPS-804), an antibody for the treatment of osteogenesis imperfecta; and Alvelestat (MPH-966), an oral small molecule that is in Phase II clinical trial to treat Alpha-1 anti-trypsin deficiency. The company has a license agreement with Feng Biosciences for the development and commercialization of navicixizumab; license agreement with ReproNovo for the development and commercialization of leflutrozole; licensing agreement with AstraZeneca; and license agreement with Ultragenyx Pharmaceutical Inc. to develop and commercialize setrusumab. Mereo BioPharma Group plc was incorporated in 2015 and is headquartered in London, the United Kingdom.","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.015037},{"month":2,"riseRate":0.428571,"avgChangeRate":0.030552},{"month":3,"riseRate":0,"avgChangeRate":-0.177922},{"month":4,"riseRate":0.666667,"avgChangeRate":0.141069},{"month":5,"riseRate":0.142857,"avgChangeRate":-0.12077},{"month":6,"riseRate":0.714286,"avgChangeRate":0.399821},{"month":7,"riseRate":0.571429,"avgChangeRate":-0.055261},{"month":8,"riseRate":0.857143,"avgChangeRate":0.105012},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.100596},{"month":10,"riseRate":0.428571,"avgChangeRate":0.068788},{"month":11,"riseRate":0.285714,"avgChangeRate":-0.101401},{"month":12,"riseRate":0.428571,"avgChangeRate":0.001557}],"exchange":"NASDAQ","name":"Mereo Biopharma Group Plc","nameEN":"Mereo Biopharma Group Plc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Mereo Biopharma Group Plc(MREO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Mereo Biopharma Group Plc(MREO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Mereo Biopharma Group Plc,MREO,Mereo Biopharma Group Plc股票,Mereo Biopharma Group Plc股票老虎,Mereo Biopharma Group Plc股票老虎国际,Mereo Biopharma Group Plc行情,Mereo Biopharma Group Plc股票行情,Mereo Biopharma Group Plc股价,Mereo Biopharma Group Plc股市,Mereo Biopharma Group Plc股票价格,Mereo Biopharma Group Plc股票交易,Mereo Biopharma Group Plc股票购买,Mereo Biopharma Group Plc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Mereo Biopharma Group Plc(MREO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Mereo Biopharma Group Plc(MREO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction